These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7333409)

  • 1. Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
    Van Dam LJ; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):323-30. PubMed ID: 7333409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study.
    Venturini PL; Horowski R; Maganza C; Morano S; Pedretti E; Ragni N; Semino F; De Cecco L
    Eur J Obstet Gynecol Reprod Biol; 1981 May; 11(6):395-400. PubMed ID: 7018950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
    Bohnet HG; Kato K; De Moll H
    Obstet Gynecol; 1988 Jan; 71(1):53-5. PubMed ID: 3336541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of lactation with lisuride.
    Hardt W; Schmidt-Gollwitzer M; Horowski R
    Gynecol Obstet Invest; 1979; 10(2-3):95-105. PubMed ID: 535777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactation-inhibiting and prolactin-lowering effect of lisuride and transdihydrolisuride. A comparative study.
    Vĕtr M; Konecný V
    Acta Univ Palacki Olomuc Fac Med; 1988; 120():295-300. PubMed ID: 2977904
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of puerperal lactation by terguride. A double-blind study.
    Venturini PL; Horowski R; Fasce V; Valenzano M; Ferreri C; Badino G; Rainer E; Scholz A; De Cecco L
    Gynecol Obstet Invest; 1988; 26(1):33-8. PubMed ID: 3049266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lactation inhibition with various dosages of lisuride--prolactin secretion and effectiveness].
    Strahl HJ; Göretzlehner G; Strahl S; Kunkel S
    Zentralbl Gynakol; 1985; 107(5):300-3. PubMed ID: 4039514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Lisuride on serum prolactin levels during puerperium.
    Venturini PL; Maganza C; Massimilla A; Campanella P; Rossato P; Ragni N; De Cecco L
    Acta Eur Fertil; 1979 Jun; 10(2):51-5. PubMed ID: 545976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lisuride on inhibition of lactation and serum prolactin.
    De Cecco L; Venturini PL; Ragni N; Rossato P; Maganza C; Gaggero G; Horowski R
    Br J Obstet Gynaecol; 1979 Nov; 86(11):905-8. PubMed ID: 508675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study.
    Utian WH; Begg G; Vinik AI; Paul M; Shuman L
    Br J Obstet Gynaecol; 1975 Sep; 82(9):755-9. PubMed ID: 1101946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 13. Endocrine and clinical results in administering lisuride for inhibiting lactation.
    Zanagnolo VL; Pollini F; Falsetti L; Gastaldi A
    Acta Eur Fertil; 1987; 18(1):21-4. PubMed ID: 3115024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of puerperal lactation. A double blind study of bromocriptine and placebo.
    Dewhurst CJ; Harrison RF; Biswas S
    Acta Obstet Gynecol Scand; 1977; 56(4):327-31. PubMed ID: 341635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic arrest of lactation. Comparison of Deprenon, lisuride, terguride and mestranol].
    Vido I; Cepický P
    Cesk Gynekol; 1989 Nov; 54(9):654-61. PubMed ID: 2624954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of lisuride, terguride and bromocriptine on intraocular pressure (IOP).
    Al-Sereiti MR; Turner P
    Br J Clin Pharmacol; 1989 Feb; 27(2):159-63. PubMed ID: 2713211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of puerperal lactation by bromocriptine.
    Rolland R; Schellekens LA
    Acta Endocrinol Suppl (Copenh); 1978; 216():119-30. PubMed ID: 347857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin response to TRH during inhibition of puerperal lactation with ergolinic drugs.
    Crosignani PG; Lombroso GC; Trojsi L; Caccamo A; Reschini E; Peracchi M
    Horm Metab Res; 1977 Mar; 9(2):163-4. PubMed ID: 405303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.